What are the clinical signs, symptoms, and laboratory abnormalities characteristic of neuroleptic malignant syndrome?

Neuroleptic Malignant Syndrome: Clinical Manifestations

Neuroleptic malignant syndrome presents with a classic tetrad of altered mental status, muscle rigidity, fever, and autonomic dysfunction, with delirium and lead-pipe rigidity being the most common neurological findings. 1

Core Clinical Features

The four cardinal symptoms typically progress in a predictable sequence, with mental status changes or rigidity appearing first in over 82% of cases, followed by hyperthermia and autonomic dysfunction: 2

Mental Status Changes

• Delirium is the most common presentation, ranging from alert mutism to agitation, stupor, or coma 1, 3
• Mental status alteration is assigned 13 points in the American Academy of Pediatrics diagnostic scoring system 3

Muscle Rigidity

• "Lead pipe" rigidity is the most common neurological finding 1, 3
• Alternative presentations include akinesia, dyskinesia, cogwheel rigidity, or waxy flexibility 1, 3
• Rigidity is assigned 17 points in the diagnostic criteria 3

Fever and Hyperthermia

• Fever can progress to severe hyperthermia, exceeding 41.1°C in extreme cases 1, 3
• Hyperthermia (>100.4°F oral on ≥2 occasions) is assigned 18 points diagnostically 3

Autonomic Dysfunction

• Tachycardia and blood pressure fluctuations often precede other symptoms 1, 3
• Excessive diaphoresis (sweating) is a frequent manifestation 1, 3
• Sialorrhea (excessive salivation) and dysphagia (difficulty swallowing) commonly occur 1, 3
• Sympathetic nervous system lability is assigned 10 points in diagnostic scoring 3

Laboratory Abnormalities

Creatine Kinase Elevation

• Elevated creatine kinase ≥4 times the upper limit of normal is a key finding 1, 3
• The median CK in documented cases is 2650 IU/L, with a range from 335 to 20,270 IU/L 3
• CK typically peaks on day 2 after fever onset and returns to normal by day 12 3
• The rising and/or falling pattern of CK is essential to distinguish NMS from baseline elevations 3

Hematologic Abnormalities

• Leukocytosis ranging from 15,000-30,000 cells/mm³ 1, 3

Other Laboratory Findings

• Electrolyte abnormalities consistent with dehydration 1, 3
• Elevated liver enzymes 1
• Metabolic acidosis in complicated cases 1

Severe Complications

• Renal failure secondary to rhabdomyolysis 1, 4
• Seizures 1, 4
• Disseminated intravascular coagulation 1, 4

Critical Diagnostic Considerations

The diagnosis of NMS is entirely clinical, with no pathognomonic laboratory criteria. 1 The American Academy of Pediatrics recommends a point-based system where ≥76 points indicates probable NMS, incorporating dopamine antagonist exposure (20 points), hyperthermia (18 points), rigidity (17 points), mental status alteration (13 points), CK elevation (10 points), sympathetic lability (10 points), hypermetabolism (5 points), and negative workup for other causes (7 points). 3

Common Pitfalls

Early recognition is crucial, as mortality has decreased from 76% in the 1960s to less than 10-15% with prompt management. 1, 3 NMS can be difficult to recognize due to variable and attenuated presentations, with symptoms developing within days after starting or increasing antipsychotic medication. 3 The diagnosis must consider clinical symptoms rather than relying solely on CK elevation, as the temporal pattern of laboratory changes is essential for accurate diagnosis. 3